Historical record - last NADAC effective date: 4/17/2024
Product Information
AMLODIPINE-OLMESARTAN 10-40 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3540 per EA under NDC 68462056990. Its NADAC has been published 222 times since Feb 19, 2020.
FDA first approved this application on Jul 5, 2017.
The High Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 40 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462056990
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/17/2024
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207807FDA Approved
7/5/2017
On Market Since
7/5/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has been published 222 times since Feb 19, 2020, and over the history we have for it it has declined 53.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3540 per EA |
|---|---|
| All-time high | $0.8689 (Jul 15, 2020) |
| All-time low | $0.2641 (Jan 17, 2024) |
| Median price | $0.4709 |
| Average price | $0.5031 |
| Largest weekly change | +47.0% (Nov 22, 2023) |
| Weeks tracked | 222 |
| Tracking since | Feb 19, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-8.4%
5Y
-32.7%
All
-53.5%
Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 10-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-40 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3540 per EA (NDC 68462056990), effective May 15, 2024.
How has the price of AMLODIPINE-OLMESARTAN 10-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has declined 53.5%. It has been tracked across 222 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-40 MG?
Since Feb 19, 2020, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has ranged from a low of $0.2641 (Jan 17, 2024) to a high of $0.8689 (Jul 15, 2020), with a median of $0.4709 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-40 MG?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-OLMESARTAN 10-40 MG, is $0.3161 per EA — about 11% below AMLODIPINE-OLMESARTAN 10-40 MG.
Who manufactures AMLODIPINE-OLMESARTAN 10-40 MG?
AMLODIPINE-OLMESARTAN 10-40 MG (NDC 68462056990) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.